Harnessing molecular metabolism through atomic-tagging technologies to enable precision measurement of biological flux activity across clinical diagnostics, translational research, and biotechnology as a new class of measurement.
● IN DEVELOPMENT
U.S. Patent Pending No. 19/270,779
International (PCT) No. PCT/US26/36378
Rapid, breath-based, point-of-care assessment of viable bacterial infection in vivo, designed to enable earlier diagnostic readout and support biologically aligned clinical decision-making.
U.S. Patent Pending No. 19/755,655
Rapid, point-of-care assessment of infected biologic samples across blood, urine, cerebrospinal fluid, bronchoalveolar lavage, peritoneal fluid, tissue suspensions, and other ex vivo biologic samples, designed to move infectious disease diagnostics beyond delayed culture, indirect biomarkers, and cohort-derived statistical inference.
U.S. Patent Pending No. 19/688,479
Continuous, real-time monitoring of pathway kinetics through direct measurement of enzymatic flux, designed to replace labor-intensive and destructive reconstruction workflows across laboratory research and industrial biotechnology.
